Clinical Trial Update: Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial (PODS) is evaluating post-operative dosing of dexamethasone in brain tumor patients after craniotomy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Malignant Glioma
• Meningioma

Drugs mentioned

• Decadron (Dexamethasone)

Snippet

Sponsor: Emory University | Conditions: Low Grade Glioma, Malignant Brain Glioma | Phase 2 | Status: RECRUITING